Shattering barriers toward clinically meaningful MSC therapies

Authors: Oren Levy, Rui Kuai, Erika M. J. Siren, Deepak Bhere, Yuka Milton, Nabeel Nissar, Michael De Biasio, Martina Heinelt, Brock Reeve, Reza Abdi, Meshael Alturki, Mohanad Fallatah, Abdulaziz Almalik, Ali H. Alhasan, Khalid Shah, Jeffrey M. Karp

Published: 2020-07-22

DOI: 10.1126/sciadv.aba6884

Source: Full article


Abstract

To realize the potential of MSCs, bioengineering is needed to boost potency and control heterogeneity.